Your browser doesn't support javascript.
loading
PIK3CA Mutational Analysis in Patients With Macrodactyly.
Becker, Jakob; Gross, Ulrike Camenisch; Weber, Daniel M; Weibel, Lisa; Theiler, Martin; Brandt, Simone; Bode, Peter K.
Afiliação
  • Becker J; Department of Pathology and Molecular Pathology, University Hospital Zürich, Zürich, Switzerland.
  • Gross UC; Department of Pathology and Molecular Pathology, University Hospital Zürich, Zürich, Switzerland.
  • Weber DM; Division of Hand Surgery, Department of Pediatric Surgery, 30995University Children's Hospital Zürich, Zürich, Switzerland.
  • Weibel L; Pediatric Skin Center, Department of Dermatology, University Children's Hospital Zürich, Zürich, Switzerland.
  • Theiler M; Pediatric Skin Center, Department of Dermatology, University Children's Hospital Zürich, Zürich, Switzerland.
  • Brandt S; Department of Pathology and Molecular Pathology, University Hospital Zürich, Zürich, Switzerland.
  • Bode PK; Institute of Pathology Medica, Zürich, Switzerland.
Pediatr Dev Pathol ; 25(6): 624-634, 2022.
Article em En | MEDLINE | ID: mdl-36314082
ABSTRACT

BACKGROUND:

Somatic mosaicism for PIK3CA mutations causes various types of growth disorders, which have been summarized under the term PROS (PIK3CA related overgrowth spectrum). Targeted therapy with PI3K inhibitors seems to be a promising alternative for severe PROS cases. Therefore, PIK3CA testing may become more relevant in the future.

METHODS:

We report on 14 PROS patients, who had surgery for macrodactyly in the majority of cases. Clinical data were retrieved from the patient's records. Macroscopic and microscopic findings were retrospectively reviewed. Mutational analysis was performed on formalin-fixed paraffin-embedded (FFPE) material.

RESULTS:

Patient age ranged from 7 months to 35 years. Five patients showed additional anomalies. One patient had CLOVES syndrome. The majority of the specimens were ray resections characterized by hypertrophic fat tissue. Overall, microscopy was subtle. The abnormal adipose tissue showed lobules exhibiting at least focally fibrous septa. In each case, we could detect a PIK3CA mutation.

CONCLUSION:

Histology of affected fat tissue in PROS patients is overall nonspecific. Therefore, mutational analysis represents the key to the diagnosis, especially in unclear clinical cases. We demonstrated that FFPE material is suitable for PIK3CA testing, which can be considered as basis for targeted therapy with PI3K inhibitors.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases / Anormalidades Musculoesqueléticas Limite: Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases / Anormalidades Musculoesqueléticas Limite: Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article